Fungal exposure and lung health study
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study looks at how environmental fungi (mold) affect lung function and asthma. Researchers need healthy volunteers without lung disease to compare results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have never had asthma, ABPA (a lung allergy to fungus), or long-term lung disease like bronchiectasis or COPD
- You do not have any allergies (like hay fever, eczema, or food allergies)
- Your lung function is normal or nearly normal
- Your blood tests (infection markers and allergy markers) are in the normal range
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system works and how well diseases like asthma, COPD, and others are controlled. You may join if you have one of these conditions or if you are a healthy volunteer or smoker without lung disease.
This study looks at how the presence of fungus in lung samples relates to the long-term outlook for people with allergic bronchopulmonary aspergillosis (ABPA). It aims to help doctors better understand the disease and guide treatment.
This study looks at airway samples from people with asthma and healthy volunteers. It helps researchers understand what causes airway problems and could lead to better treatments.
This trial tests a procedure that uses a bronchoscope to clean mucus from the airways and then spray the antifungal drug amphotericin B directly into the lungs. It may help people whose ABPA is active and not improving with standard treatments.
This study follows people with moderate-to-severe asthma and repeatedly checks how their lungs and symptoms relate to environmental exposures over time. It may help researchers better understand what triggers asthma and how exposures affect asthma control.
This study tests whether benralizumab, a biologic medicine, works well in real-world settings for people with severe asthma caused by an allergic reaction to a common mold called Aspergillus. You may qualify if you have hard-to-control asthma despite strong medications and recent asthma flare-ups.
Hear when a new Environmental Exposure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.